LDL cholesterol targets are more aggressive with <100 mg/dL for most without risk factors, <70 mg/dL for higher risk, and <55 mg/dL for those with existing heart disease, reflecting a trend toward lower targets to reduce lifelong risk.

Guideline supports LDL-C goals of <100 mg/dL for borderline/intermediate risk, <70 mg/dL for high risk, and <55 mg/dL for very high-risk ASCVD, noting that further lowering LDL-C generally provides greater protection.

The package includes multimedia briefings and official guideline hubs, with related editorials and publications in JACC and Circulation.

New guidance introduces routine testing for apoB and lipoprotein(a) and emphasizes measuring lifetime risk in addition to 10-year risk using a PREVENT calculator for ages 30 to 79.

Experts stress prevention begins early through lifestyle changes, with medications used to manage lifelong risk rather than only short-term risk.

Hypertriglyceridemia management centers on lifestyle changes and statins, with consideration of additional therapies based on ASCVD and pancreatitis risk.

The guideline addresses treatment timing for CKD, HIV, diabetes, cancer patients, and pregnancy, and recommends cholesterol screening for all children aged 9–11 to assess future ASCVD risk.

Updated guidelines from major cardiology groups urge earlier screening and treatment, starting in people’s 30s, to prevent heart attack and stroke.

Risk enhancers and biomarkers (family history, inflammatory/metabolic conditions, ancestry, reproductive markers, Lp(a), apoB, hsCRP, triglycerides) refine risk and tailor lipid-lowering therapy.

There's a shift from 10-year risk to incorporating 30-year and lifetime risk for more personalized, preventive care and earlier intervention.

Endorsements come from multiple professional organizations, with the guideline intended for clinician implementation to reduce future cardiovascular disease burden.

A joint ACC and AHA update with nine other associations consolidates evidence-based dyslipidemia and ASCVD risk recommendations into a single document in JACC and Circulation.